SenesTech, Inc. (NASDAQ:SNES – Get Free Report) saw a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 174,900 shares, a decrease of 30.7% from the March 15th total of 252,400 shares. Based on an average daily trading volume, of 121,600 shares, the short-interest ratio is currently 1.4 days. Currently, 12.0% of the company’s stock are short sold.
SenesTech Trading Up 3.2 %
NASDAQ SNES opened at $1.95 on Friday. The company has a market cap of $3.41 million, a PE ratio of -0.20 and a beta of -0.03. SenesTech has a 12 month low of $1.30 and a 12 month high of $9.80. The stock has a 50 day moving average of $2.36 and a 200-day moving average of $2.66. The company has a current ratio of 6.32, a quick ratio of 4.92 and a debt-to-equity ratio of 0.05.
SenesTech (NASDAQ:SNES – Get Free Report) last announced its quarterly earnings data on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, beating analysts’ consensus estimates of ($1.50) by $0.28. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. The company had revenue of $0.50 million during the quarter, compared to the consensus estimate of $0.71 million. On average, equities research analysts anticipate that SenesTech will post -10.22 EPS for the current fiscal year.
Wall Street Analyst Weigh In
View Our Latest Analysis on SNES
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
See Also
- Five stocks we like better than SenesTech
- Consumer Discretionary Stocks Explained
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- Where to Find Earnings Call Transcripts
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- Pros And Cons Of Monthly Dividend Stocks
- AppLovin: Can Record Profits Overcome Market Skepticism?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.